At the end of Q2 2024, 25 institutions reported holding Telomir Pharmaceuticals Inc. (TELO) in their 13F filings, up 18 from Q1 2024. 19 opened new positions and 2 sold out. The largest holders were BlackRock Inc. ($423K), Geode Capital Management, LLC ($319K) and Bank of New York Mellon Corp ($241K).
Company
Telomir Pharmaceuticals Inc.
CUSIP
87975F104
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
Institutions
Total Value
New Positions
19
$1.5M
Exits
2
$154K
All 13F filers, Q1 2024 → Q2 2024: 320,636 shares bought and 41,649 shares sold, net +278,987 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.